Assignee
BIONTECH AG
DE·31 granted patents·17 pending applications·82 citations·filing 2008–2023
Top patents by PatentIndex Score
48 records- 0196US10106800B2Modification of RNA, producing an increased transcript stability and translation efficiencyBIONTECH AG·Filed 2016·Granted Oct 23, 2018·18 cites·11 claims
- 0292US9267177B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2015·Granted Feb 23, 2016·6 cites·7 claims
- 0390US10717780B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2018·Granted Jul 21, 2020·5 cites·12 claims
- 0487US10980875B2Cytotoxic immunostimulating particles and uses thereofBIONTECH AG·Filed 2016·Granted Apr 20, 2021·2 cites·13 claims
- 0587US9950065B2Particles comprising a shell with RNABIONTECH AG·Filed 2013·Granted Apr 24, 2018·12 cites·20 claims
- 0687US9533043B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Jan 3, 2017·7 cites·5 claims
- 0786US10604568B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2014·Granted Mar 31, 2020·6 cites·10 claims
- 0886US9194004B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2013·Granted Nov 24, 2015·6 cites·4 claims
- 0985US11787862B2Bispecific trivalent antibodies binding to Claudin6 or Claudin18.2 and CD3 for treatment of Claudin expressing cancer diseasesBIONTECH AG·Filed 2017·Granted Oct 17, 2023·3 cites·32 claims
- 1084US10724103B2Identification of surface associated antigen FLJ31461 for tumor diagnosis and therapyBIONTECH AG·Filed 2017·Granted Jul 28, 2020·1 cites·3 claims
- 1184US10093736B2Agents for treatment of claudin expressing cancer diseasesBIONTECH AG·Filed 2013·Granted Oct 9, 2018·7 cites·9 claims
- 1280US11628209B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2018·Granted Apr 18, 2023·1 cites·15 claims
- 1379US10172960B2Particles comprising single stranded RNA and double stranded RNA for immunomodulationBIONTECH AG·Filed 2017·Granted Jan 8, 2019·1 cites·11 claims
- 1478US2024059772A1Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2023·Application pending·0 cites
- 1577US10253373B2Identification of tumor-associated markers for diagnosis and therapyBIONTECH AG·Filed 2017·Granted Apr 9, 2019·1 cites·5 claims
- 1676US10188712B2Tumor antigens for determining cancer therapyBIONTECH AG·Filed 2014·Granted Jan 29, 2019·3 cites·7 claims
- 1774US2024228616A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2022·Application pending·0 cites
- 1871US11008550B2Use of RNA for reprogramming somatic cellsBIONTECH AG·Filed 2019·Granted May 18, 2021·0 cites·4 claims
- 1970US2022347308A1Methods and means for inducing an immune responseBIONTECH AG·Filed 2022·Application pending·0 cites
- 2069US10550430B2Method and kit for determining whether a subject shows an immune responseBIONTECH AG·Filed 2014·Granted Feb 4, 2020·1 cites·20 claims
- 2168US10858415B2Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2014·Granted Dec 8, 2020·1 cites·15 claims
- 2267US11795218B2Diagnosis and therapy of cancer involving cancer stem cellsBIONTECH AG·Filed 2020·Granted Oct 24, 2023·0 cites·22 claims
- 2367US2019062762A1Modification of RNA, Producing an Increased Transcript Stability and Translation EfficiencyBIONTECH AG·Filed 2018·Application pending·0 cites
- 2466US9910043B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2016·Granted Mar 6, 2018·0 cites·7 claims
- 2565US10302647B2Identification of surface-associated antigens for tumor diagnosis and therapyBIONTECH AG·Filed 2016·Granted May 28, 2019·0 cites·8 claims
- 2665US2020031898A1Peptide mimotopes of claudin 18.2 and uses thereofBIONTECH AG·Filed 2019·Application pending·0 cites
- 2765US2020399370A1Agents for Treatment of Claudin Expressing Cancer DiseasesBIONTECH AG·Filed 2020·Application pending·0 cites
- 2864US10370433B2Compositions and methods for diagnosis and treatment of cancerBIONTECH AG·Filed 2016·Granted Aug 6, 2019·1 cites·16 claims
- 2964US9637794B2Genetic products differentially expressed in tumors and use thereofBIONTECH AG·Filed 2013·Granted May 2, 2017·0 cites·10 claims
- 3063US9139880B2Identification of tumor-associated cell surface antigens for diagnosis and therapyBIONTECH AG·Filed 2013·Granted Sep 22, 2015·0 cites·7 claims
- 3162US2014134201A1Recombinant vaccines and use thereofBIONTECH AG·Filed 2014·Application pending·0 cites
- 3261US9617321B2Tumor vaccination involving a humoral immune response against self-proteinsBIONTECH AG·Filed 2014·Granted Apr 11, 2017·0 cites·20 claims
- 3360US10626400B2Stabilised formulations of RNABIONTECH AG·Filed 2014·Granted Apr 21, 2020·0 cites·10 claims
- 3460US9139639B2Polynucleotides encoding an intracellular segment of CD40 and a constant region of an immunoglobulin heavy chainBIONTECH AG·Filed 2014·Granted Sep 22, 2015·0 cites·14 claims
- 3559US9061007B2Compositions and methods for therapy and diagnosis of cancer and cancer metastasisBIONTECH AG·Filed 2013·Granted Jun 23, 2015·0 cites·9 claims
- 3658US2016002738A1Genetic products differentially expressed in tumors and use thereofBIONTECH AG·Filed 2015·Application pending·0 cites
- 3758US2017080068A1Identification of Tumor-Associated Antigens for Diagnosis and TherapyBIONTECH AG·Filed 2016·Application pending·0 cites
- 3857US10526387B2Tumor vaccination involving a humoral immune response against self-proteinsBIONTECH AG·Filed 2016·Granted Jan 7, 2020·0 cites·12 claims
- 3957US2017218342A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2017·Application pending·0 cites
- 4056US10457735B2Methods of inducing T cell activation by administering an antibody comprising CD40 and 4-1BB (CD137) binding domainsBIONTECH AG·Filed 2016·Granted Oct 29, 2019·0 cites·3 claims
- 4156US9944708B2Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZe (antibody-mediated apoptosis inducing cytokines)BIONTECH AG·Filed 2014·Granted Apr 17, 2018·0 cites·5 claims
- 4255US2018318436A1Methods and means for inducing an immune responseBIONTECH AG·Filed 2016·Application pending·0 cites
- 4354US2016215351A1Identification of Tumor-Associated Markers for Diagnosis and TherapyBIONTECH AG·Filed 2016·Application pending·0 cites
- 4453US2016122721A1Use of rna for reprogramming somatic cellsBIONTECH AG·Filed 2015·Application pending·0 cites
- 4550US2020340065A1Methods and kits for the molecular subtyping of tumorsBIONTECH AG·Filed 2020·Application pending·0 cites
- 4648US2015247206A1Compositions and Methods for Therapy and Diagnosis of Cancer and Cancer MetastasisBIONTECH AG·Filed 2015·Application pending·0 cites
- 4746US2010267610A1Polypeptide comprising a knottin protein moietyBIONTECH AG·Filed 2008·Application pending·0 cites
- 4845US2017007776A1Cannula, an injection or infusion device and methods of using the cannula or the injection or infusion deviceBIONTECH AG·Filed 2014·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →